[Evaluation of sclerosis treatment based on blood circulation or vascular lesions].
D000328:Adult; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000098:blood supply / Q000473:pathology; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator